madurahydroxylactone

Known as: MHL cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2016
0119992016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
FtsZ, a bacterial cell-division protein, is an attractive antibacterial target. In the screening for an inhibitor of… (More)
Is this relevant?
2016
2016
The maritime environment presents a unique set of challenges to search and recovery (SAR) operations. There is a paucity of… (More)
Is this relevant?
2010
2010
Madurahydroxylactone (MHL), a secondary metabolite with antibacterial activity was evaluated for its suitability to generate… (More)
Is this relevant?
2008
2008
A series of 29 madurahydroxylactone derivatives was evaluated for dual inhibition of human immunodeficiency virus type 1 (HIV-1… (More)
Is this relevant?
2007
2007
Thiosemicarbazones of the microbial metabolite madurahydroxylactone, a polysubstituted benzo[a]naphthacenequinone, have been… (More)
Is this relevant?
2002
2002
Madurahydroxylactone (MHL) is a secondary metabolite produced by the soil bacterium Nonomuria rubra and belongs to the family of… (More)
Is this relevant?
1999
1999
Madurahydroxylactone is a secondary metabolite from Nonomuria rubra (former Actinomadura rubra) with in vitro activity against… (More)
Is this relevant?